TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A PHASE 2, 16 WEEK, MULTICENTER, RANDOMIZED, DOUBLE BLIND PLACEBO CONTROLLED, PARALLEL GROUP PROOF OF CONCEPT STUDY EVALUATING THE EFFICACY AND SAFETY OF PF-04383119 FOR THE TREATMENT OF PAIN ASSOCIATED WITH INTERSTITIAL CYSTITIS
Brief Summary: The purpose of this study is to determine whether PF-04383119 is effective in the treatment of pain associated with interstitial cystitis.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: PF-04383119 | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: PF-04383119; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
B: Arm Label: Botulinum toxin; Type: ACTIVE_COMPARATOR; Interventions: Procedure: intratrigonal injection of botulinum toxin | Arm Label: cystoscopy with hydrodistension; Type: SHAM_COMPARATOR; Interventions: Procedure: cystoscopy | Intervention Type: PROCEDURE; Name: intratrigonal injection of botulinum toxin; Assigned to Arm(s): Botulinum toxin | Intervention Type: PROCEDURE; Name: cystoscopy; Assigned to Arm(s): cystoscopy with hydrodistension
C: Arm Label: Pelvic Floor Physical Therapy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Pelvic Floor Physical Therapy | Arm Label: Bladder Instillations; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bladder Instillations | Intervention Type: PROCEDURE; Name: Pelvic Floor Physical Therapy; Assigned to Arm(s): Pelvic Floor Physical Therapy | Intervention Type: DRUG; Name: Bladder Instillations; Assigned to Arm(s): Bladder Instillations
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Device: Placebo | Arm Label: Low energy shock wave; Type: EXPERIMENTAL; Interventions: Device: Low energy shock wave | Intervention Type: DEVICE; Name: Low energy shock wave; Assigned to Arm(s): Low energy shock wave | Intervention Type: DEVICE; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Group Interventions for Abused, Suicidal Black Women
Brief Summary: This study will evaluate the effectiveness of culturally competent psychoeducational empowerment sessions in treating suicidal African-American women who are in abusive relationships.


Options:
A: Arm Label: Teachable Moment Brief Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Teachable Moment Brief Intervention | Arm Label: Care as Usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Teachable Moment Brief Intervention; Assigned to Arm(s): Teachable Moment Brief Intervention
B: Arm Label: Compassion meditation (CM); Type: EXPERIMENTAL; Interventions: Behavioral: Compassion meditation (CM) | Arm Label: Support group (SG); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Support group (SG) | Intervention Type: BEHAVIORAL; Name: Compassion meditation (CM); Assigned to Arm(s): Compassion meditation (CM) | Intervention Type: BEHAVIORAL; Name: Support group (SG); Assigned to Arm(s): Support group (SG)
C: Arm Label: Psychoeducational intervention (PEI); Type: EXPERIMENTAL; Interventions: Behavioral: Psychoeducational intervention (PEI) | Arm Label: Enhanced Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced treatment as usual (ETAU) | Intervention Type: BEHAVIORAL; Name: Psychoeducational intervention (PEI); Assigned to Arm(s): Psychoeducational intervention (PEI) | Intervention Type: BEHAVIORAL; Name: Enhanced treatment as usual (ETAU); Assigned to Arm(s): Enhanced Treatment as Usual
D: Arm Label: brief intervention to prevent suicide attempt; Type: EXPERIMENTAL; Interventions: Behavioral: Brief intervention to prevent suicide attempt | Arm Label: standard of care; Type: OTHER; Interventions: Behavioral: Enhanced treatment as usual | Intervention Type: BEHAVIORAL; Name: Brief intervention to prevent suicide attempt; Assigned to Arm(s): brief intervention to prevent suicide attempt | Intervention Type: BEHAVIORAL; Name: Enhanced treatment as usual; Assigned to Arm(s): standard of care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Group Interventions for Abused, Suicidal Black Women
Brief Summary: This study will evaluate the effectiveness of culturally competent psychoeducational empowerment sessions in treating suicidal African-American women who are in abusive relationships.


Options:
A: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: General Psychiatric Management | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical Behaviour Therapy | Intervention Type: BEHAVIORAL; Name: General Psychiatric Management; Assigned to Arm(s): A | Intervention Type: BEHAVIORAL; Name: Dialectical Behaviour Therapy; Assigned to Arm(s): 2
B: Arm Label: Psychoeducational intervention (PEI); Type: EXPERIMENTAL; Interventions: Behavioral: Psychoeducational intervention (PEI) | Arm Label: Enhanced Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced treatment as usual (ETAU) | Intervention Type: BEHAVIORAL; Name: Psychoeducational intervention (PEI); Assigned to Arm(s): Psychoeducational intervention (PEI) | Intervention Type: BEHAVIORAL; Name: Enhanced treatment as usual (ETAU); Assigned to Arm(s): Enhanced Treatment as Usual
C: Arm Label: Dialectical Behavior Therapy Fluoxetine; Type: EXPERIMENTAL; Interventions: Drug: Fluoxetine, Behavioral: Dialectical Behavior Therapy | Arm Label: Dialectical Behavior Therapy placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Dialectical Behavior Therapy | Arm Label: Supportive therapy Fluoxetine; Type: EXPERIMENTAL; Interventions: Drug: Fluoxetine, Behavioral: Supportive psychotherapy | Arm Label: Supportive therapy placebo; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supportive psychotherapy | Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): Dialectical Behavior Therapy Fluoxetine, Supportive therapy Fluoxetine | Intervention Type: BEHAVIORAL; Name: Dialectical Behavior Therapy; Assigned to Arm(s): Dialectical Behavior Therapy Fluoxetine, Dialectical Behavior Therapy placebo | Intervention Type: BEHAVIORAL; Name: Supportive psychotherapy; Assigned to Arm(s): Supportive therapy Fluoxetine, Supportive therapy placebo
D: Arm Label: SAFE VET; Type: N/A; Interventions: Behavioral: SAFE VET | Arm Label: E-CARE; Type: N/A; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SAFE VET; Assigned to Arm(s): SAFE VET

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Group Interventions for Abused, Suicidal Black Women
Brief Summary: This study will evaluate the effectiveness of culturally competent psychoeducational empowerment sessions in treating suicidal African-American women who are in abusive relationships.


Options:
A: Arm Label: Psychoeducational intervention (PEI); Type: EXPERIMENTAL; Interventions: Behavioral: Psychoeducational intervention (PEI) | Arm Label: Enhanced Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced treatment as usual (ETAU) | Intervention Type: BEHAVIORAL; Name: Psychoeducational intervention (PEI); Assigned to Arm(s): Psychoeducational intervention (PEI) | Intervention Type: BEHAVIORAL; Name: Enhanced treatment as usual (ETAU); Assigned to Arm(s): Enhanced Treatment as Usual
B: Arm Label: Cognitive behavioral therapy (CBT) + standard care; Type: EXPERIMENTAL; Interventions: Behavioral: CBT, Behavioral: Standard care alone | Arm Label: Standard care alone; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard care alone | Intervention Type: BEHAVIORAL; Name: CBT; Assigned to Arm(s): Cognitive behavioral therapy (CBT) + standard care | Intervention Type: BEHAVIORAL; Name: Standard care alone; Assigned to Arm(s): Cognitive behavioral therapy (CBT) + standard care, Standard care alone
C: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: General Psychiatric Management | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical Behaviour Therapy | Intervention Type: BEHAVIORAL; Name: General Psychiatric Management; Assigned to Arm(s): A | Intervention Type: BEHAVIORAL; Name: Dialectical Behaviour Therapy; Assigned to Arm(s): 2
D: Arm Label: COPESS and Treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Other: COPESS | Arm Label: Treatment as usual only; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: COPESS; Assigned to Arm(s): COPESS and Treatment as usual

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: CBT Augmentation of SSRI Treatment for Geriatric GAD
Brief Summary: This study will assess whether adding cognitive behavioral therapy to the antidepressant escitalopram is effective in reducing anxiety in older adults with generalized anxiety disorder.


Options:
A: Arm Label: Cognitive therapy plus medications; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Therapy, Drug: Medications | Arm Label: Medications alone; Type: EXPERIMENTAL; Interventions: Drug: Medications | Intervention Type: BEHAVIORAL; Name: Cognitive Therapy; Assigned to Arm(s): Cognitive therapy plus medications | Intervention Type: DRUG; Name: Medications; Assigned to Arm(s): Cognitive therapy plus medications, Medications alone
B: Arm Label: Open-Label Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Venlafaxine XR | Arm Label: Double-Blind Drug Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Venlafaxine XR | Arm Label: Double-Blind Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Double-Blind Drug-After-Drug Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Venlafaxine XR | Arm Label: Double-Blind Placebo-After-Drug Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Double-Blind Placebo-After-Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Venlafaxine XR; Assigned to Arm(s): Double-Blind Drug Group, Double-Blind Drug-After-Drug Group, Open-Label Group | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Double-Blind Placebo Group, Double-Blind Placebo-After-Drug Group, Double-Blind Placebo-After-Placebo Group
C: Arm Label: CBT/Escitalopram; Type: EXPERIMENTAL; Interventions: Drug: Escitalopram, Behavioral: Cognitive behavioral therapy (CBT) | Arm Label: No CBT/escitalopram; Type: ACTIVE_COMPARATOR; Interventions: Drug: Escitalopram | Arm Label: CBT/placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Behavioral: Cognitive behavioral therapy (CBT) | Arm Label: No CBT/placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): CBT/Escitalopram, No CBT/escitalopram | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): CBT/placebo, No CBT/placebo | Intervention Type: BEHAVIORAL; Name: Cognitive behavioral therapy (CBT); Assigned to Arm(s): CBT/Escitalopram, CBT/placebo
D: Arm Label: Supported Protocolized Discontinuation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supported Protocolized Discontinuation (SPD) | Arm Label: SPD + Mindfulness (MBCT); Type: EXPERIMENTAL; Interventions: Behavioral: Supported Protocolized Discontinuation (SPD), Behavioral: Mindfulness Based Cognitive Therapy (MBCT) | Intervention Type: BEHAVIORAL; Name: Supported Protocolized Discontinuation (SPD); Assigned to Arm(s): SPD + Mindfulness (MBCT), Supported Protocolized Discontinuation | Intervention Type: BEHAVIORAL; Name: Mindfulness Based Cognitive Therapy (MBCT); Assigned to Arm(s): SPD + Mindfulness (MBCT)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Early and Late Cardiac Effects of Arteriovenous Fistula Creation for Haemodialysis in End-stage Renal Failure and Their Possible Attenuation
Brief Summary: The primary objective is to determine if the use of losartan, an angiotensin II receptor blocker, can attenuate left ventricular hypertrophy, independent of its antihypertensive effects, in patients with near end stage chronic kidney disease (CKD) who have an arteriovenous fistula created.

Secondary outcomes include the impact of the medication on BNP and hyperkalaemia


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Metoprolol controlled release (CR) | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Metoprolol controlled release (CR); Assigned to Arm(s): A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): B
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Ramipril; Type: EXPERIMENTAL; Interventions: Drug: Ramipril | Arm Label: Spironolactone; Type: EXPERIMENTAL; Interventions: Drug: Spironolactone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Ramipril; Assigned to Arm(s): Ramipril | Intervention Type: DRUG; Name: Spironolactone; Assigned to Arm(s): Spironolactone
C: Intervention Type: DRUG; Name: losartan; Assigned to Arm(s): N/A
D: Arm Label: Metoprolol; Type: EXPERIMENTAL; Interventions: Drug: Metoprolol | Arm Label: Placebo for Metoprolol; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Candesartan; Type: EXPERIMENTAL; Interventions: Drug: Candesartan | Arm Label: Placebo for Candesartan; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Metoprolol; Assigned to Arm(s): Metoprolol | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo for Metoprolol | Intervention Type: DRUG; Name: Candesartan; Assigned to Arm(s): Candesartan | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo for Candesartan

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment of PTSD in Recently Battered Women Living in Shelters
Brief Summary: This study will evaluate the effectiveness of a brief cognitive behavioral treatment, Helping to Overcome PTSD through Empowerment, in treating abused women with post-traumatic stress disorder who are living in shelters.


Options:
A: Arm Label: Control - VSLA; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Control - Mental Health; Type: OTHER; Interventions: Behavioral: Treatment as usual | Arm Label: Voluntary Savings/Loans Assoc; Type: EXPERIMENTAL; Interventions: Behavioral: Voluntary Savings/Loans Assoc | Arm Label: Cognitive Processing Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): Control - Mental Health | Intervention Type: BEHAVIORAL; Name: Voluntary Savings/Loans Assoc; Assigned to Arm(s): Voluntary Savings/Loans Assoc | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): Cognitive Processing Therapy
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Helping to Overcome PTSD through Empowerment (HOPE) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as usual | Intervention Type: BEHAVIORAL; Name: Helping to Overcome PTSD through Empowerment (HOPE); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): 2
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Public Health Nurse Home Visit | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intimate Partner Violence (IPV) Protocol | Intervention Type: BEHAVIORAL; Name: Public Health Nurse Home Visit; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Intimate Partner Violence (IPV) Protocol; Assigned to Arm(s): 2
D: Arm Label: Qigong training; Type: EXPERIMENTAL; Interventions: Behavioral: Qigong training | Arm Label: Wait-list control- Health talks; Type: OTHER; Interventions: Other: Wait-list control- Health talks | Intervention Type: BEHAVIORAL; Name: Qigong training; Assigned to Arm(s): Qigong training | Intervention Type: OTHER; Name: Wait-list control- Health talks; Assigned to Arm(s): Wait-list control- Health talks

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Comparison Between Intravaginal Dinoprostone Intravaginal Misoprostol and Transcervical Balloon Catheter for Labour Induction
Brief Summary: This is a randomised study aimed at comparing the currently most frequently used prostaglandin dinoprostone to two other methods, the cheaper and perhaps more effective prostaglandin misoprostol and a transcervical catheter. 592 women were recruited and randomised to one of the three methods. The main outcome measures were time to delivery, rate of instrumental deliveries and maternal neonatal outcome. Our hypothesis was that misoprostol would be superior to the other methods.

The main finding of our trial was that the catheter showed the shortest induction to delivery interval. There were no differences between the two other prostaglandins. No differences in maternal and neonatal outcome was found


Options:
A: Arm Label: Mechanical cervical ripening; Type: EXPERIMENTAL; Interventions: Device: Mechanical cervical ripening | Arm Label: Pharmacological cervical ripening; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pharmacological cervical ripening | Intervention Type: DEVICE; Name: Mechanical cervical ripening; Assigned to Arm(s): Mechanical cervical ripening | Intervention Type: DRUG; Name: Pharmacological cervical ripening; Assigned to Arm(s): Pharmacological cervical ripening
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: misoprostol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: dinoprostone | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Device: Bard Catheter (balloon catheter) | Intervention Type: DRUG; Name: misoprostol; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: dinoprostone; Assigned to Arm(s): 2 | Intervention Type: DEVICE; Name: Bard Catheter (balloon catheter); Assigned to Arm(s): 3
C: Arm Label: FOLEY BALLOON; Type: ACTIVE_COMPARATOR; Interventions: Device: FOLEY BALLOON | Arm Label: CERVIDIL; Type: ACTIVE_COMPARATOR; Interventions: Drug: CERVIDIL (Dinoprostone) | Intervention Type: DRUG; Name: CERVIDIL (Dinoprostone); Assigned to Arm(s): CERVIDIL | Intervention Type: DEVICE; Name: FOLEY BALLOON; Assigned to Arm(s): FOLEY BALLOON
D: Arm Label: Oxytocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxytocin | Arm Label: Foley Catheter and Oxytocin; Type: EXPERIMENTAL; Interventions: Device: Foley Catheter, Drug: Oxytocin | Intervention Type: DEVICE; Name: Foley Catheter; Assigned to Arm(s): Foley Catheter and Oxytocin | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Foley Catheter and Oxytocin, Oxytocin

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Comparison Between Intravaginal Dinoprostone Intravaginal Misoprostol and Transcervical Balloon Catheter for Labour Induction
Brief Summary: This is a randomised study aimed at comparing the currently most frequently used prostaglandin dinoprostone to two other methods, the cheaper and perhaps more effective prostaglandin misoprostol and a transcervical catheter. 592 women were recruited and randomised to one of the three methods. The main outcome measures were time to delivery, rate of instrumental deliveries and maternal neonatal outcome. Our hypothesis was that misoprostol would be superior to the other methods.

The main finding of our trial was that the catheter showed the shortest induction to delivery interval. There were no differences between the two other prostaglandins. No differences in maternal and neonatal outcome was found


Options:
A: Arm Label: Cook Cervical balloon; Type: ACTIVE_COMPARATOR; Interventions: Device: Cook cervical balloon | Arm Label: Prostin E2 Vaginal suppository; Type: ACTIVE_COMPARATOR; Interventions: Drug: Prostin E2 Vaginal Suppository | Intervention Type: DEVICE; Name: Cook cervical balloon; Assigned to Arm(s): Cook Cervical balloon | Intervention Type: DRUG; Name: Prostin E2 Vaginal Suppository; Assigned to Arm(s): Prostin E2 Vaginal suppository
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Induction of labor with foley balloon - 60cc of saline | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Induction of labor with foley balloon with 30cc | Intervention Type: PROCEDURE; Name: Induction of labor with foley balloon - 60cc of saline; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Induction of labor with foley balloon with 30cc; Assigned to Arm(s): 2
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: Foley catheter | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: Atad catheter | Intervention Type: DEVICE; Name: Foley catheter; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: Atad catheter; Assigned to Arm(s): 2
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: misoprostol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: dinoprostone | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Device: Bard Catheter (balloon catheter) | Intervention Type: DRUG; Name: misoprostol; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: dinoprostone; Assigned to Arm(s): 2 | Intervention Type: DEVICE; Name: Bard Catheter (balloon catheter); Assigned to Arm(s): 3

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Placebo Controlled Trial of Sertraline and Interpersonal Psycho-Therapy for Postpartum Depression
Brief Summary: This study will evaluate the effectiveness of antidepressant medication alone and interpersonal psychotherapy alone in treating women with postpartum depression.


Options:
A: Arm Label: 1 (Placebo); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Behavioral: Clinical management, Behavioral: Mothercrafting | Arm Label: 2 (Sertraline); Type: ACTIVE_COMPARATOR; Interventions: Drug: Sertraline, Behavioral: Clinical management, Behavioral: Mothercrafting | Arm Label: 3 (IPT); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Interpersonal psychotherapy (IPT) | Intervention Type: DRUG; Name: Sertraline; Assigned to Arm(s): 2 (Sertraline) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 1 (Placebo) | Intervention Type: BEHAVIORAL; Name: Interpersonal psychotherapy (IPT); Assigned to Arm(s): 3 (IPT) | Intervention Type: BEHAVIORAL; Name: Clinical management; Assigned to Arm(s): 1 (Placebo), 2 (Sertraline) | Intervention Type: BEHAVIORAL; Name: Mothercrafting; Assigned to Arm(s): 1 (Placebo), 2 (Sertraline)
B: Arm Label: sertraline, psychotherapy; Type: EXPERIMENTAL; Interventions: Drug: Sertraline, Other: psychotherapy | Arm Label: placebo, psychotherapy; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo, Other: psychotherapy | Intervention Type: DRUG; Name: Sertraline; Assigned to Arm(s): sertraline, psychotherapy | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo, psychotherapy | Intervention Type: OTHER; Name: psychotherapy; Assigned to Arm(s): placebo, psychotherapy, sertraline, psychotherapy
C: Arm Label: PND-MCI; Type: EXPERIMENTAL; Interventions: Other: multi-component intervention | Arm Label: usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Intervention Type: OTHER; Name: multi-component intervention; Assigned to Arm(s): PND-MCI | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): usual care
D: Arm Label: TAU; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: TAU | Arm Label: DCM; Type: EXPERIMENTAL; Interventions: Behavioral: Care Management for Postpartum Depression | Intervention Type: BEHAVIORAL; Name: Care Management for Postpartum Depression; Assigned to Arm(s): DCM | Intervention Type: BEHAVIORAL; Name: TAU; Assigned to Arm(s): TAU

Answer: A